mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |